Isogenica, Biolauncher and Cresset Biomolecular Discovery forge alliance to bring powerful target-to-drugs platform to market
Joint venture aims to rapidly identify small molecule therapeutics to pharma targets Cambridge, UK, June 28th, 2011 Isogenica Ltd today ...